Skip to main content
Clinical Trials/NCT01741571
NCT01741571
Completed
Not Applicable

Randomized Controlled Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques

American University of Beirut Medical Center1 site in 1 country32 target enrollmentDecember 2012
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
American University of Beirut Medical Center
Enrollment
32
Locations
1
Primary Endpoint
Sensitivity of each needle aspiration technique for diagnosis of malignancy
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) techniques have not been well studied. The investigators will conduct a randomized study comparing the diagnostic yield and specimen quality of EBUS-FNA performed with and without suction applied.

Detailed Description

Consecutive patients with suspected malignant peribronchial masses or lymph nodes undergoing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will be enrolled. All participants will have 4 needle aspirations of each targeted peribronchial lesion. Two needle aspirations will be performed while applying suction and 2 needle aspirations will be performed without applying suction in random order. The investigators will compare the diagnostic yield and the quality of the specimens obtained using the two techniques.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
January 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hassan Chami

Assistant Professor

American University of Beirut Medical Center

Eligibility Criteria

Inclusion Criteria

  • Adult undergoing EBUS at AUBMC for suspected malignancy

Exclusion Criteria

  • Coagulopathy
  • The lesion cannot be sampled because of intervening tumor or blood vessels.

Outcomes

Primary Outcomes

Sensitivity of each needle aspiration technique for diagnosis of malignancy

Time Frame: Diagnosis of malignancy will be ascertained after 6 month clinical follow up

A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The sensitivity for diagnosing malignancy will be calculated and compared for the two needle aspiration technique.

Diagnostic accuracy of each needle aspiration technique for diagnosis of malignancy

Time Frame: Diagnosis of malignancy will be ascertained after 6 month clinical follow up

A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The diagnostic accuracy for diagnosing malignancy will be assessed and compared for the two needle aspiration technique.

Secondary Outcomes

  • Negative predicted value of each needle aspiration technique for diagnosis of malignancy(Diagnosis of malignancy will be ascertained after 6 month of clinical follow up)
  • Positive predicted value of each needle aspiration technique for diagnosis of malignancy(Diagnosis of Malignancy will be ascertained after 6 month of clinical follow up)
  • Adequacy of the needle aspiration sample(Adequacy will be assessed within 1 week from procedure)
  • Specificity of each needle aspiration technique for diagnosis of malignancy(Diagnosis of malignancy will be ascertained after 6 month clinical follow up)

Study Sites (1)

Loading locations...

Similar Trials